Nonacus ExomeCG Exome Capture Kit

Nonacus of Birmingham, UK, has launched ExomeCG, a "clinically enhanced" exome capture kit that is designed to enable whole-exome sequencing and targeted copy number analysis in a single assay. According to the company's website, the kit provides CNV detection at loci known to have both gene- and exon-level rearrangements, which enables researchers to replace array- and MLPA-based CNV analyses. Codeveloped with bioinformatics firm Congenica, ExomeCG can be used in combination with that company's clinical decision support platform to interpret next-generation sequencing data for clinical decision making, Nonacus said.